These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 38918441)
1. Pan-cancer multi-omics analysis of PTBP1 reveals it as an inflammatory, progressive and prognostic marker in glioma. Ye Z; Zhong Y; Zhang Z Sci Rep; 2024 Jun; 14(1):14584. PubMed ID: 38918441 [TBL] [Abstract][Full Text] [Related]
2. PTBP1 is a Novel Poor Prognostic Factor for Glioma. Liu P; He GC; Tan YZ; Liu GX; Liu AM; Zhu XP; Zhou Y; Hu WM Biomed Res Int; 2022; 2022():7590997. PubMed ID: 35299889 [TBL] [Abstract][Full Text] [Related]
3. PTBP1-mediated repression of neuron-specific CDC42 splicing constitutes a genomic alteration-independent, developmentally conserved vulnerability in IDH-wildtype glioblastoma. Yang J; Feng J; Lv J; Chu X; Wei Y; Zhang Y; Li J; Sun Y; Li G; Jiang T; Huang J; Fan X Funct Integr Genomics; 2024 Aug; 24(4):135. PubMed ID: 39117866 [TBL] [Abstract][Full Text] [Related]
4. Automated fluorescent miscroscopic image analysis of PTBP1 expression in glioma. Kaya B; Goceri E; Becker A; Elder B; Puduvalli V; Winter J; Gurcan M; Otero JJ PLoS One; 2017; 12(3):e0170991. PubMed ID: 28282372 [TBL] [Abstract][Full Text] [Related]
5. PTBP1 as a Promising Predictor of Poor Prognosis by Regulating Cell Proliferation, Immunosuppression, and Drug Sensitivity in SARC. Gong H; Jiang A; Jiang R; Wang Y; Zhang D; Wu Z; Xiao J Oxid Med Cell Longev; 2022; 2022():5687238. PubMed ID: 35651729 [TBL] [Abstract][Full Text] [Related]
6. Lnc00462717 regulates the permeability of the blood-brain tumor barrier through interaction with PTBP1 to inhibit the miR-186-5p/Occludin signaling pathway. Zhang C; Zhang X; Wang J; Di F; Xue Y; Lin X; Zhang Y; Zhang H; Zhang Z; Gu Y FASEB J; 2020 Aug; 34(8):9941-9958. PubMed ID: 32623796 [TBL] [Abstract][Full Text] [Related]
7. Prognostic prediction and immune checkpoint profiling in glioma patients through neddylation-associated features. Qi J; Li L; Gao B; Dai K; Shen K; Wu X; Li H; Yu Z; Wang Z; Wang Z Gene; 2024 Dec; 930():148835. PubMed ID: 39127414 [TBL] [Abstract][Full Text] [Related]
8. Ferroptosis-related gene signature correlates with the tumor immune features and predicts the prognosis of glioma patients. Hu Y; Tu Z; Lei K; Huang K; Zhu X Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34726238 [TBL] [Abstract][Full Text] [Related]
9. A pan-cancer analysis of the oncogenic role of polypyrimidine tract binding protein 1 (PTBP1) in human tumors. Huang Q; Gu S; Fang J; Li X; Lin L Medicine (Baltimore); 2022 Dec; 101(52):e32428. PubMed ID: 36595978 [TBL] [Abstract][Full Text] [Related]
10. Cuproptosis-related gene-located DNA methylation in lower-grade glioma: Prognosis and tumor microenvironment. Zhu L; Yuan F; Wang X; Zhu R; Guo W Cancer Biomark; 2024; 40(2):185-198. PubMed ID: 38578883 [TBL] [Abstract][Full Text] [Related]
11. Lowly expressed lncRNA PVT1 suppresses proliferation and advances apoptosis of glioma cells through up-regulating microRNA-128-1-5p and inhibiting PTBP1. Dahai Z; Daliang C; Famu L; Xiang W; Lenian L; Jianmin C; Xiaobing X Brain Res Bull; 2020 Oct; 163():1-13. PubMed ID: 32562719 [TBL] [Abstract][Full Text] [Related]
12. The Splicing Factor PTBP1 Promotes Expression of Oncogenic Splice Variants and Predicts Poor Prognosis in Patients with Non-muscle-Invasive Bladder Cancer. Bielli P; Panzeri V; Lattanzio R; Mutascio S; Pieraccioli M; Volpe E; Pagliarulo V; Piantelli M; Giannantoni A; Di Stasi SM; Sette C Clin Cancer Res; 2018 Nov; 24(21):5422-5432. PubMed ID: 30012566 [No Abstract] [Full Text] [Related]
13. [Single-cell transcriptome analysis of multigrade glioma heterogeneity and immune microenvironment revealed potential prognostic biomarkers]. Liu J; Xu K; Ma L; Wang Y Sheng Wu Gong Cheng Xue Bao; 2022 Oct; 38(10):3790-3808. PubMed ID: 36305410 [TBL] [Abstract][Full Text] [Related]
14. Mitochondrial RNA modification-based signature to predict prognosis of lower grade glioma: a multi-omics exploration and verification study. Zhou X; Ling Y; Cui J; Wang X; Long N; Teng W; Liu J; Xiang X; Yang H; Chu L Sci Rep; 2024 Jun; 14(1):12602. PubMed ID: 38824202 [TBL] [Abstract][Full Text] [Related]
15. p53-targeted lncRNA ST7-AS1 acts as a tumour suppressor by interacting with PTBP1 to suppress the Wnt/β-catenin signalling pathway in glioma. Sheng J; He X; Yu W; Chen Y; Long Y; Wang K; Zhu S; Liu Q Cancer Lett; 2021 Apr; 503():54-68. PubMed ID: 33476649 [TBL] [Abstract][Full Text] [Related]
16. FAM109B plays a tumorigenic role in low-grade gliomas and is associated with tumor-associated macrophages (TAMs). Zhang Z; Xiao Y; Zhao S; Liu J; Zeng J; Xiao F; Liao B; Shan X; Zhu H; Guo H J Transl Med; 2024 Sep; 22(1):833. PubMed ID: 39256832 [TBL] [Abstract][Full Text] [Related]
17. Splicing factors PTBP1 and PTBP2 promote proliferation and migration of glioma cell lines. Cheung HC; Hai T; Zhu W; Baggerly KA; Tsavachidis S; Krahe R; Cote GJ Brain; 2009 Aug; 132(Pt 8):2277-88. PubMed ID: 19506066 [TBL] [Abstract][Full Text] [Related]
18. Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy. Teng C; Zhu Y; Li Y; Dai L; Pan Z; Wanggou S; Li X Front Immunol; 2022; 13():899710. PubMed ID: 35677036 [TBL] [Abstract][Full Text] [Related]
19. The alternative splicing of intersectin 1 regulated by PTBP1 promotes human glioma progression. Lan C; Zhang H; Wang K; Liu X; Zhao Y; Guo Z; Zhang N; Zhou Y; Gao M; Gu F; Ma Y Cell Death Dis; 2022 Sep; 13(9):835. PubMed ID: 36171198 [TBL] [Abstract][Full Text] [Related]
20. PTBP1 induces ADAR1 p110 isoform expression through IRES-like dependent translation control and influences cell proliferation in gliomas. Yang B; Hu P; Lin X; Han W; Zhu L; Tan X; Ye F; Wang G; Wu F; Yin B; Bao Z; Jiang T; Yuan J; Qiang B; Peng X Cell Mol Life Sci; 2015 Nov; 72(22):4383-97. PubMed ID: 26047657 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]